CRBP
Price
$9.90
Change
-$0.57 (-5.44%)
Updated
Aug 28 closing price
Capitalization
121.33M
XBIT
Price
$3.28
Change
-$0.11 (-3.24%)
Updated
Aug 29, 10:58 AM (EDT)
Capitalization
103.35M
69 days until earnings call
Interact to see
Advertisement

CRBP vs XBIT

Header iconCRBP vs XBIT Comparison
Open Charts CRBP vs XBITBanner chart's image
Corbus Pharmaceuticals Holdings
Price$9.90
Change-$0.57 (-5.44%)
Volume$65.57K
Capitalization121.33M
XBiotech
Price$3.28
Change-$0.11 (-3.24%)
Volume$100
Capitalization103.35M
CRBP vs XBIT Comparison Chart in %
Loading...
CRBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBP vs. XBIT commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBP is a StrongBuy and XBIT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (CRBP: $9.90 vs. XBIT: $3.39)
Brand notoriety: CRBP and XBIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBP: 44% vs. XBIT: 29%
Market capitalization -- CRBP: $121.33M vs. XBIT: $103.35M
CRBP [@Biotechnology] is valued at $121.33M. XBIT’s [@Biotechnology] market capitalization is $103.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBP’s FA Score shows that 0 FA rating(s) are green whileXBIT’s FA Score has 0 green FA rating(s).

  • CRBP’s FA Score: 0 green, 5 red.
  • XBIT’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBP is a better buy in the long-term than XBIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBP’s TA Score shows that 6 TA indicator(s) are bullish while XBIT’s TA Score has 6 bullish TA indicator(s).

  • CRBP’s TA Score: 6 bullish, 3 bearish.
  • XBIT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CRBP is a better buy in the short-term than XBIT.

Price Growth

CRBP (@Biotechnology) experienced а +2.06% price change this week, while XBIT (@Biotechnology) price change was +5.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +15.09%, and the average quarterly price growth was +29.14%.

Reported Earning Dates

XBIT is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBP($121M) has a higher market cap than XBIT($103M). XBIT YTD gains are higher at: -14.177 vs. CRBP (-16.102). XBIT has higher annual earnings (EBITDA): -25.88M vs. CRBP (-57.15M). XBIT has more cash in the bank: 153M vs. CRBP (117M). CRBP has less debt than XBIT: CRBP (2.46M) vs XBIT (10M). CRBP (0) and XBIT (0) have equivalent revenues.
CRBPXBITCRBP / XBIT
Capitalization121M103M117%
EBITDA-57.15M-25.88M221%
Gain YTD-16.102-14.177114%
P/E RatioN/AN/A-
Revenue00-
Total Cash117M153M76%
Total Debt2.46M10M25%
FUNDAMENTALS RATINGS
CRBP vs XBIT: Fundamental Ratings
CRBP
XBIT
OUTLOOK RATING
1..100
2428
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4848
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9015

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRBP's Valuation (47) in the Biotechnology industry is in the same range as XBIT (71). This means that CRBP’s stock grew similarly to XBIT’s over the last 12 months.

CRBP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as XBIT (100). This means that CRBP’s stock grew similarly to XBIT’s over the last 12 months.

CRBP's SMR Rating (100) in the Biotechnology industry is in the same range as XBIT (100). This means that CRBP’s stock grew similarly to XBIT’s over the last 12 months.

CRBP's Price Growth Rating (48) in the Biotechnology industry is in the same range as XBIT (48). This means that CRBP’s stock grew similarly to XBIT’s over the last 12 months.

CRBP's P/E Growth Rating (100) in the Biotechnology industry is in the same range as XBIT (100). This means that CRBP’s stock grew similarly to XBIT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRBPXBIT
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 10 days ago
65%
Declines
ODDS (%)
Bearish Trend about 1 month ago
90%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
CRBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SHLLF1.360.03
+2.54%
Shelf Drilling Ltd.
DNIYY33.48N/A
N/A
Danieli S.p.A.- Officine Meccaniche Danieli & C.
NNOCF0.18N/A
N/A
Nanoco Group Plc
WKGFF0.05N/A
N/A
Westkam Gold Corp.
UPMMY28.66-0.19
-0.66%
UPM-Kymmene Corp.

CRBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBP has been loosely correlated with SKYE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBP jumps, then SKYE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBP
1D Price
Change %
CRBP100%
-5.44%
SKYE - CRBP
48%
Loosely correlated
+0.58%
FBIO - CRBP
40%
Loosely correlated
+3.42%
APLS - CRBP
34%
Loosely correlated
-0.60%
STOK - CRBP
34%
Loosely correlated
+2.44%
XBIT - CRBP
31%
Poorly correlated
-2.59%
More